The PI3K/Akt/GSK-3β signaling pathway is one of the crucial signaling pathways and therapeutic targets for neuroprotection against cerebral ischemia injury (Miyawaki et al., 2009; Lu et al., 2011; Dong et al., 2021). Here, AKT1 is linked to Cerebral ischemia.